ESENYSECommunications Equipment, NEC

Esco Technologies Inc (ESE) earnings date, market-implied expected move, and options open interest by expiry

239.32

−11.27 · −4.50%

Regular session15:59 ET

Open251.15Volume284,817Mkt cap$6.2BP/E19.65EPS12.18Div yield0.13%

Day236.49 – 251.1519%52-wk193.44 – 361.9627%

ESE

Esco Technologies Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±4.6%implied · report alone

8Q avg ±6.9%·×0.67·cheap

228.85250.87

straddle ±6.7%

spot 239.86exp Nov 20ATM strike 240ATM straddle 18.80IV 47%

Nov 4 closereport share · term structurethin chain

Expected move

Inputs

Next report

Nov 19

after close · in 14 days

est.Q4 FY26

Calendar

Next report

Last report

−6.80%

vs ±7.3% implied · ×0.93

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

Largest filed tie

13F top-10 QoQ

+8.71%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

447 managers

Top fund weight

0.29%

ESE weight · IWM

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Esco Technologies (ESE) is expected to report on Nov 19 after close (estimated date). Implied ±4.6%, either direction. 3 of the last 8 reports moved at least as far as the implied move.

Implied vs realized

8 reports

3 of 8≥ implied

avg implied: ±5.8%
avg realized: ±6.9%

Feb 6 '25Feb 6 '25confirmed±6.1%▲+19.75%×3.23

May 7 '25May 7 '25confirmed±7.2%▲+6.30%×0.88

Aug 7 '25Aug 7 '25confirmed±5.8%▲+1.79%×0.31

Nov 20 '25Nov 20 '25confirmed±5.5%▲+2.54%×0.46

Q1 FY26Feb 5 '26confirmed±6.3%▲+6.17%×0.98

Q2 FY26Apr 15 '26confirmed±1.7%▼−2.56%×1.47

May 7 '26May 7 '26confirmed±6.3%▼−8.91%×1.42

Q3 FY26Aug 6 '26confirmed±7.3%▼−6.80%×0.93

quarterimplied−20%0+20%realized×

Q3 FY26±7.3%▼−6.80%×0.93

May '26±6.3%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 4 close

2.18OI · 3 expiries · Nov 4 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

240%

Positioning

Linked exposure

scenario · straddle±6.7%

Funds 4

IWM±0.0%

Linked exposure

Revenue flow

as filedQ3 FY26

9.66%as filednet margin · revenue +9.60% QoQ · +14.40% YoY

Revenue

$339M+9.60% QoQ

Gross profit

$142M+7.77% QoQ

41.74% margin

Operating income

$50M+7.36% QoQ

14.65% margin

Pre-tax income

$41M−6.63% QoQ

Net income

$33M−5.75% QoQ

9.66% margin

Cost of revenue

$198M+10.94% QoQ

Operating expenses

$92M+8.00% QoQ

SG&A $71M

Other operating $508,000

Other operating $20M

Other expense

$9M

Tax

$8M−20.27% QoQ

Revenue$339M+9.60%

Gross profit

$142M+7.77%

41.74% margin

Operating income

$50M+7.36%

14.65% margin

Pre-tax income

$41M−6.63%

Net income

$33M−5.75%

9.66% margin

Cost of revenue

$198M+10.94%

Operating expenses

$92M+8.00%

SG&A $71M

Other operating $508,000

Other operating $20M

Other expense

$9M

Tax$8M−20.27%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

NFP ×1.98· ±2.9% vs ±1.5% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±2.9%5 of 10×1.98

Esco Technologies Inc (ESE) earnings date, market-implied expected move, and options open interest by expiry

Implied vs realized

Implied vs realized

Positioning

Positioning

Linked exposure

Linked exposure

Revenue flow

Revenue flow

Intraday

Intraday

Event sensitivity

Revenue flow

Implied vs realized

Positioning

Linked exposure

Event sensitivity

Earnings history

Methodology

Intraday

Esco Technologies Inc (ESE) earnings date, market-implied expected move, and options open interest by expiry

Quarter	Reported	EPS	Consensus
Q3 FY26	Aug 6 '26 · confirmed	1.26	—
Q2 FY26	Apr 15 '26 · confirmed	1.34	—
Q1 FY26	Feb 5 '26 · confirmed	1.11	—